-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOVIE ENROLLS FIRST PATIENT IN ADDRESS-LC CLINICAL TRIAL ASSESSING NOVEL ANTI-INFLAMMATORY CANDIDATE BEZISTERIM FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS ASSOCIATED WITH LONG COVID

Reuters·05/15/2025 12:00:02

Please log in to view news